Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function ...

Dr. Trista Newville and Dr. Jennifer Jaggi clear up misconceptions around the commonly misunderstood disease. Sponsored by ...

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Odofin explained that while emergency procedures like cesarean sections can often be performed with basic investigations, ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.

The reproductive organs are the key biological components that differentiate women from men. The organs include the uterus, ...

Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...

High-Intensity Focused Ultrasound treatment, popularly known as HIFU, is fast becoming a game-changer in the management of tumours, prostate cancer and enlargement, as well as other conditions ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an international ...

Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm disorders such as atrial fibrillation (AFib) Pulsed field ablation – or ...